← All trials
NCT05734560
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 6, 2023
- Primary completion
- Feb 28, 2026
- Completion date
- Feb 29, 2028
- First posted
- Feb 21, 2023
- Last posted
- Sep 21, 2023
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Duke UniversityLead sponsor
- Rockefeller UniversityCollaborator
- Duke UniversityOverall official - principal investigator
- Duke UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.